Clinical trial

MEND 2: Making Treatment Decisions Using Genomic Testing

NCT03183050

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-06-02

PhaseNA

Study timeline

Study start (actual)2017-06-02Date precision: day

Registry last updated2025-04-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Femaleunresolved

Interventions

Question Prompt ListBEHAVIORAL

Sponsors & collaborators

Georgetown Universitylead sponsor

H. Lee Moffitt Cancer Center and Research Institutecollaborator

Barbara Ann Karmanos Cancer Institutecollaborator

Mapped research locations

TampaFlorida, United States1 Washington D.C.District of Columbia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03183050 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.